# A Study To Assess A Novel Form Of Cataract Treatment Using The Non-Invasive REVISYON Proof-Of-Concept Device

> **NCT04569318** · NA · COMPLETED · sponsor: **Edinburgh Biosciences Ltd** · enrollment: 11 (actual)

## Conditions studied

- Cataract

## Interventions

- **DEVICE:** Treatment Beam

## Key facts

- **NCT ID:** NCT04569318
- **Lead sponsor:** Edinburgh Biosciences Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-19
- **Primary completion:** 2021-08-19
- **Final completion:** 2021-09-09
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04569318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04569318, "A Study To Assess A Novel Form Of Cataract Treatment Using The Non-Invasive REVISYON Proof-Of-Concept Device". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04569318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*